Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
該当コードがありません。
から:
次の項目別のソート:
日付受信時刻ニュースソース見出しコード企業名
2024/08/0105 : 05GlobeNewswire Inc.Teladoc Health Reports Second Quarter 2024 ResultsNYSE:TDOCTeladoc Health Inc
2024/08/0105 : 05GlobeNewswire Inc.Udemy Reports Second Quarter 2024 ResultsNASDAQ:UDMYUdemy Inc
2024/08/0105 : 05GlobeNewswire Inc.MediaAlpha Announces Second Quarter 2024 Financial ResultsNYSE:MAXMediaAlpha Inc
2024/08/0105 : 05Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:VXXiPath Series B S&P 500 VIX ShortTerm Futures ETN
2024/08/0105 : 05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NVNOenVVeno Medical Corporation
2024/08/0105 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EMKREMCORE Corporation
2024/08/0105 : 05Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:VXXiPath Series B S&P 500 VIX ShortTerm Futures ETN
2024/08/0105 : 05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:DFINDonnelley Financial Solutions Inc
2024/08/0105 : 05Edgar (US Regulatory)Form 8-K - Current reportUSOTC:VBIXViewBix Inc (PK)
2024/08/0105 : 05Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:JPM-MJP Morgan Chase and Co
2024/08/0105 : 05Edgar (US Regulatory)Form 8-K - Current reportNYSE:TDOCTeladoc Health Inc
2024/08/0105 : 05Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:CODACoda Octopus Group Inc
2024/08/0105 : 05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GMMGlobal Mofy Metaverse Ltd
2024/08/0105 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CVKDCadrenal Therapeutics Inc
2024/08/0105 : 05GlobeNewswire Inc.Biomea Fusion Reports Second Quarter 2024 Financial Results and Corporate HighlightsNASDAQ:BMEABiomea Fusion Inc
2024/08/0105 : 05Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:BCLIBrainstorm Cell Therapeutics Inc
2024/08/0105 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCBITexas Capital Bancshares Inc
2024/08/0105 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTGTTech Target Inc
2024/08/0105 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTGTTech Target Inc
2024/08/0105 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CNXNPC Connection Inc
2024/08/0105 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTGTTech Target Inc
2024/08/0105 : 05Edgar (US Regulatory)Form 8-K - Current reportNYSE:ZETAZeta Global Holdings Corp
2024/08/0105 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HLVXHilleVax Inc
2024/08/0105 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTGTTech Target Inc
2024/08/0105 : 05GlobeNewswire Inc.Revolution Medicines to Report Financial Results for Second Quarter 2024 After Market Close on August 7, 2024NASDAQ:RVMDRevolution Medicines Inc
2024/08/0105 : 05Edgar (US Regulatory)Form 8-K - Current reportNYSE:TSLXSixth Street Specialty Lending Inc
2024/08/0105 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EVEREverQuote Inc
2024/08/0105 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GENKGEN Restaurant Group Inc
2024/08/0105 : 05Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:FIACUFocus Impact Acquisition Corporation
2024/08/0105 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VKTXViking Therapeutics Inc

最近閲覧した銘柄